Clinical trials
Recruiting Muscular Dystrophies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leigh R. Hochberg, MD, PhD. | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| The Duchenne Registry | 2 |
| University of Florida | 2 |
| Virginia Commonwealth University | 2 |
| Anne M. Connolly | 1 |
| Avidity Biosciences, Inc. | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Catalyst Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophies | 37 |
| Muscular Dystrophy, Duchenne | 13 |
| Myotonic Dystrophy | 7 |
| Spinal Cord Injuries | 6 |
| Neuromuscular Diseases | 5 |
| Amyotrophic Lateral Sclerosis | 4 |
| Brain Stem Infarctions | 4 |
| Muscular Diseases | 4 |
| Quadriplegia | 4 |
| Locked-In Syndrome | 3 |
Trials
Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.